Hangzhou Coco Healthcare Products Co.,Ltd.
SZSE:301009.SZ
11.3 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 280.18 | 289.431 | 268.234 | 236.196 | 282.967 | 274.716 | 244.169 | 243.805 | 318.794 | 337.168 | 272.995 | 254.492 | 321.635 | 319.801 | 236.316 | 297.538 | 332.749 | 401.937 | 433.923 | 485.521 | 313.751 | 364.457 |
| Cost of Revenue
| 212.11 | 235.054 | 212.664 | 185.342 | 225.27 | 232.675 | 193.817 | 198.175 | 265.893 | 298.99 | 237.729 | 223.117 | 282.821 | 295.618 | 190.983 | 230.386 | 248.322 | 305.57 | 335.119 | 308.982 | 230.435 | 258.596 |
| Gross Profit
| 68.07 | 54.377 | 55.57 | 50.854 | 57.697 | 42.041 | 50.352 | 45.63 | 52.901 | 38.178 | 35.266 | 31.375 | 38.814 | 24.183 | 45.333 | 67.152 | 84.427 | 96.367 | 98.804 | 176.539 | 83.315 | 105.861 |
| Gross Profit Ratio
| 0.243 | 0.188 | 0.207 | 0.215 | 0.204 | 0.153 | 0.206 | 0.187 | 0.166 | 0.113 | 0.129 | 0.123 | 0.121 | 0.076 | 0.192 | 0.226 | 0.254 | 0.24 | 0.228 | 0.364 | 0.266 | 0.29 |
| Reseach & Development Expenses
| 11.783 | 12.183 | 11.136 | 10.407 | 10.216 | 10.87 | 11.25 | 11.554 | 10.432 | 13.042 | 12.844 | 13.734 | 11.364 | 13.306 | 12.335 | 12.952 | 10.681 | 11.754 | 18.812 | 18.644 | 9.63 | 16.834 |
| General & Administrative Expenses
| 11.826 | -10.59 | 20.774 | -3.383 | 8.895 | -14.388 | 22.831 | -2.171 | 6.379 | 7.831 | 17.217 | -1.275 | 6.559 | -10.13 | 21.92 | -2.133 | 5.514 | -27.666 | 29.045 | -15.183 | 4.968 | -78.907 |
| Selling & Marketing Expenses
| 24.807 | -9.753 | 50.424 | 36.121 | 23.105 | 30.701 | 25.504 | 22.361 | 20.904 | 24.654 | 20.751 | 27.598 | 22.177 | 27.631 | 25.778 | 18.826 | 18.45 | 20.519 | 14.875 | 16.34 | 13.703 | 34.948 |
| SG&A
| 36.632 | -20.343 | 71.198 | 41.892 | 32.001 | 16.313 | 48.334 | 20.189 | 27.283 | 34.052 | 37.968 | 26.323 | 28.737 | 17.501 | 47.699 | 16.694 | 23.964 | -7.148 | 43.92 | 1.158 | 18.671 | -43.959 |
| Other Expenses
| -2.238 | 54.262 | -23.06 | -1.702 | 0.086 | -0.035 | 1.985 | -2.584 | -0.145 | 57.249 | 0.128 | -0.15 | 0.024 | -0.581 | -1.257 | 0.073 | -0.006 | 0 | 0 | -2.627 | -1.109 | 0 |
| Operating Expenses
| 46.177 | 46.103 | 59.274 | 54 | 41.644 | 45.595 | 47.826 | 43.043 | 38.706 | 104.342 | 38.765 | 48.093 | 40.409 | 51.441 | 52.16 | 37.49 | 35.702 | 27.948 | 44.675 | 38.569 | 27.591 | 75.696 |
| Operating Income
| 21.893 | 8.274 | -3.704 | -3.146 | 20.802 | -8.442 | 5.217 | 11.253 | 12.204 | -66.164 | 14.203 | -3.927 | 0.42 | -36.183 | 2.591 | 30.917 | 47.977 | 57.049 | 42.666 | 97.993 | 57.682 | 27.74 |
| Operating Income Ratio
| 0.078 | 0.029 | -0.014 | -0.013 | 0.074 | -0.031 | 0.021 | 0.046 | 0.038 | -0.196 | 0.052 | -0.015 | 0.001 | -0.113 | 0.011 | 0.104 | 0.144 | 0.142 | 0.098 | 0.202 | 0.184 | 0.076 |
| Total Other Income Expenses Net
| -0.115 | -0.308 | 1.828 | 9.074 | 0.086 | -0.035 | -0.169 | -0.43 | -0.145 | -0.906 | 0.128 | -0.15 | 0.024 | -0.581 | -1.257 | 0.073 | -0.006 | 0.007 | 0.013 | -0.002 | -1.109 | -0.118 |
| Income Before Tax
| 21.778 | 7.967 | -1.876 | 6.612 | 20.888 | -8.477 | 5.048 | 10.823 | 12.058 | -67.07 | 14.33 | -4.077 | 0.444 | -36.764 | 1.335 | 30.991 | 47.97 | 57.056 | 42.678 | 97.991 | 56.573 | 27.622 |
| Income Before Tax Ratio
| 0.078 | 0.028 | -0.007 | 0.028 | 0.074 | -0.031 | 0.021 | 0.044 | 0.038 | -0.199 | 0.052 | -0.016 | 0.001 | -0.115 | 0.006 | 0.104 | 0.144 | 0.142 | 0.098 | 0.202 | 0.18 | 0.076 |
| Income Tax Expense
| 3.163 | -0.623 | -0.464 | 0.742 | 2.684 | -0.401 | 0.5 | 0.716 | 0.876 | 2.091 | 0.559 | -1.97 | -0.806 | -3.52 | -0.731 | 2.487 | 5.858 | 11.098 | 5.959 | 12.381 | 7.068 | 7.243 |
| Net Income
| 18.59 | 9.102 | -1.144 | 4.883 | 18.332 | -7.018 | 5.317 | 10.789 | 11.097 | -57.9 | 14.216 | -1.403 | 1.957 | -29.704 | 2.086 | 27.115 | 40.248 | 45.959 | 36.719 | 84.007 | 47.326 | 20.379 |
| Net Income Ratio
| 0.066 | 0.031 | -0.004 | 0.021 | 0.065 | -0.026 | 0.022 | 0.044 | 0.035 | -0.172 | 0.052 | -0.006 | 0.006 | -0.093 | 0.009 | 0.091 | 0.121 | 0.114 | 0.085 | 0.173 | 0.151 | 0.056 |
| EPS
| 0.07 | 0.035 | -0.004 | 0.018 | 0.067 | -0.021 | 0.02 | 0.04 | 0.041 | -0.22 | 0.052 | -0.005 | 0.007 | -0.11 | -0.075 | 0.13 | 0.2 | 0.23 | 0.18 | 0.41 | 0.23 | 0 |
| EPS Diluted
| 0.07 | 0.035 | -0.004 | 0.018 | 0.067 | -0.021 | 0.02 | 0.04 | 0.041 | -0.22 | 0.052 | -0.005 | 0.007 | -0.11 | -0.075 | 0.13 | 0.2 | 0.23 | 0.18 | 0.41 | 0.23 | 0 |
| EBITDA
| 22.106 | 8.209 | -1.723 | 22.291 | 23.999 | -8.297 | 21.013 | 26.193 | 27.287 | -0.816 | 30.788 | 12.989 | 17.527 | -21.234 | 15.932 | 35.447 | 50.834 | 62.558 | 87.736 | 97.993 | 65.65 | 31.342 |
| EBITDA Ratio
| 0.079 | 0.028 | -0.006 | 0.094 | 0.085 | -0.03 | 0.086 | 0.107 | 0.086 | -0.002 | 0.113 | 0.051 | 0.054 | -0.066 | 0.067 | 0.119 | 0.153 | 0.156 | 0.202 | 0.202 | 0.209 | 0.086 |